Opening the OPK Assay Gatekeeper: Harnessing Multi-Modal Protection by Pneumococcal Vaccines

Pneumococcal vaccine development is driven by the achievement of high activity in a single gatekeeper assay: the bacterial opsonophagocytic killing (OPK) assay. New evidence challenges the dogma that anti-capsular antibodies have only a single function that predicts success. The emerging concept of...

Descripción completa

Detalles Bibliográficos
Autores principales: Riegler, Ashleigh N., Mann, Beth, Orihuela, Carlos J., Tuomanen, Elaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963391/
https://www.ncbi.nlm.nih.gov/pubmed/31652741
http://dx.doi.org/10.3390/pathogens8040203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963391/
https://www.ncbi.nlm.nih.gov/pubmed/31652741
http://dx.doi.org/10.3390/pathogens8040203

Ejemplares similares